title: Experimental infection of cynomolgus macaques with Ebola-Reston filoviruses from the 1989-1990 U.S. epizootic.
abstract: This study describes the pathogenesis of the Ebola-Reston (EBO-R) subtype of Ebola virus for experimentally infected cynomolgus monkeys. The disease course of EBO-R in macaques was very similar to human disease and to experimental diseases in macaques following EBO-Zaire and EBO-Sudan infections. Cynomolgus monkeys infected with EBO-R in this experiment developed anorexia, occasional nasal discharge, and splenomegaly, petechial facial hemorrhages and severe subcutaneous hemorrhages in venipuncture sites, similar to human Ebola fever. Five of the six EBO-R infected monkeys died, 8 to 14 days after inoculation. One survived and developed high titered neutralizing antibodies specific for EBO-R. The five acutely ill monkeys shed infectious virus in various bodily secretions. Further, abundant virus was visualized in alveolar interstitial cells and free in the alveoli suggesting the potential for generating infectious aerosols. Thus, taking precautions against aerosol exposures to filovirus infected primates, including humans, seems prudent. This experiment demonstrated that EBO-R was lethal for macaques and was capable of initiating and sustaining the monkey epizootic. Further investigation of this animal model should facilitate development of effective immunization, treatment, and control strategies for Ebola hemorrhagic fever.
authors.affiliation: United States Army Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland 21702-5011, USA.
authors.forename: P B
authors.initials: PB
authors.lastname: Jahrling
authors.forename: T W
authors.initials: TW
authors.lastname: Geisbert
authors.forename: N K
authors.initials: NK
authors.lastname: Jaax
authors.forename: M A
authors.initials: MA
authors.lastname: Hanes
authors.forename: T G
authors.initials: TG
authors.lastname: Ksiazek
authors.forename: C J
authors.initials: CJ
authors.lastname: Peters
mesh_terms: D000818:Animals; D000914:Antibodies, Viral / Q000097:blood; D002522:Chlorocebus aethiops; D029043:Ebolavirus / Q000302:isolation & purification* / Q000472:pathogenicity* / Q000648:ultrastructure; D004797:Enzyme-Linked Immunosorbent Assay; D019084:Fluorescent Antibody Technique, Indirect; D019142:Hemorrhagic Fever, Ebola / Q000503:physiopathology* / Q000635:transmission / Q000662:veterinary; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D008099:Liver / Q000473:pathology / Q000821:virology; D008168:Lung / Q000473:pathology / Q000821:virology; D008198:Lymph Nodes / Q000473:pathology / Q000821:virology; D008252:Macaca fascicularis / Q000821:virology*; D008854:Microscopy, Electron; D016253:Microscopy, Immunoelectron; D018419:Primate Diseases; D012469:Salivary Glands / Q000473:pathology / Q000821:virology; D013154:Spleen / Q000473:pathology / Q000821:virology; D001743:Urinary Bladder / Q000473:pathology / Q000821:virology; D014709:Vero Cells; D014771:Virion / Q000302:isolation & purification / Q000648:ultrastructure
chemical_list: D000914:Antibodies, Viral; D007074:Immunoglobulin G